{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T03:55:39Z","timestamp":1774065339240,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.ejps.2008.07.005","type":"journal-article","created":{"date-parts":[[2008,7,30]],"date-time":"2008-07-30T08:34:42Z","timestamp":1217406882000},"page":"264-270","source":"Crossref","is-referenced-by-count":21,"title":["Presystemic elimination of budesonide in man when administered locally at different levels in the gut, with and without local inhibition by ketoconazole"],"prefix":"10.1016","volume":"35","author":[{"given":"Janeric","family":"Seideg\u00e5rd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Nyberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olof","family":"Borg\u00e5","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2008.07.005_bib1","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2165\/00003088-200443120-00003","article-title":"Pharmacokinetics of budesonide (Entocort EC) capsules for Crohn's disease","volume":"43","author":"Edsb\u00e4cker","year":"2004","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2008.07.005_bib2","first-page":"525","article-title":"A pharmacoscintigraphic evaluation of oral budesonide given as controlled-release (Entocort) capsules Aliment","volume":"17","author":"Edsb\u00e4cker","year":"2003","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2008.07.005_bib3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1073\/pnas.84.1.265","article-title":"Expression of a multidrug-resistance gene in human tumors and tissues","volume":"84","author":"Fojo","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejps.2008.07.005_bib4","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/hep.510240407","article-title":"Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin","volume":"24","author":"Fromm","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.ejps.2008.07.005_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0090-9556(24)15271-3","article-title":"Molecular and physical mechanisms of first-pass extraction","volume":"27","author":"Hall","year":"1999","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/j.ejps.2008.07.005_bib6","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/clpt.1992.171","article-title":"Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction","volume":"52","author":"Hebert","year":"1992","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2008.07.005_bib7","first-page":"1121","article-title":"The nifedipine-rifampin interaction Evidence for induction of gut wall metabolism","volume":"24","author":"Holtbecker","year":"1996","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2008.07.005_bib8","first-page":"137","article-title":"Budesonide is metabolized by cytochrome P450 3A (CYP3A) enzymes in human liver","volume":"23","author":"J\u00f6nsson","year":"1995","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/j.ejps.2008.07.005_bib9","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/0140-6736(91)92302-I","article-title":"First-pass metabolism of cyclosporin by the gut","volume":"338","author":"Kolars","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2008.07.005_bib10","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1172\/JCI116064","article-title":"Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes","volume":"90","author":"Kolars","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejps.2008.07.005_bib11","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1124\/mol.62.1.162","article-title":"Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism","volume":"62","author":"Lin","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejps.2008.07.005_bib12","first-page":"947","article-title":"Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test","volume":"22","author":"Lown","year":"1994","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/j.ejps.2008.07.005_bib13","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ejps.2007.01.005","article-title":"A convenient method for local administration at predefined sites in the entire gastrointestinal tract: experiences from 13 phase I studies","volume":"30","author":"Nyberg","year":"2007","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2008.07.005_bib14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0009-9236(96)90162-9","article-title":"First-pass metabolism of midazolam by the human intestine","volume":"60","author":"Paine","year":"1996","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2008.07.005_bib15","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0022-3565(24)37149-6","article-title":"Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism","volume":"283","author":"Paine","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2008.07.005_bib16","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/clpt.1984.71","article-title":"Kinetics of the epimeric glucocorticoid budesonide","volume":"35","author":"Ryrfeldt","year":"1984","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2008.07.005_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1067\/mcp.2000.106895","article-title":"Reduction of the inhibitory effect of ketoconazole on budesonide pharmacokinetics by separation of their time of administration","volume":"68","author":"Seideg\u00e5rd","year":"2000","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2008.07.005_bib18","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0009-9236(96)90177-0","article-title":"Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism","volume":"59","author":"Thummel","year":"1996","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2008.07.005_bib19","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1021\/js980082d","article-title":"Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics","volume":"87","author":"Wacher","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2008.07.005_bib20","series-title":"Physiological Pharmaceutics. Barriers to drug absorption","author":"Washington","year":"2001"},{"key":"10.1016\/j.ejps.2008.07.005_bib21","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/0009-9236(95)90168-X","article-title":"Differentiation of absorption and first-pass gut and hepatic metabolism in humans: studies with cyclosporine","volume":"58","author":"Wu","year":"1995","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2008.07.005_bib22","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0090-9556(24)15229-4","article-title":"Characterization of human small intestinal cytochromes P-450","volume":"27","author":"Zhang","year":"1999","journal-title":"Drug. Metab. Dispos."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098708003370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098708003370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T06:59:47Z","timestamp":1738306787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098708003370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0928098708003370"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2008.07.005","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}